Your email and its content will be used to provide you an answerto your message. You have the possibility to access, to modify, to rectify and to suppress any personal data concerning you.
To exercise this right, please click here.
Ipsen at a glance
The group in 2015
23 May 2016 - Paris (France)
Ipsen’s partner Exelixis announced results from randomized phase 2 trial CABOSUN that demonstrate that cabozantinib significantly…